Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
South Africa’s Aspen Group is acquiring an active pharmaceutical ingredients business and the option to buy 11 finished products from Merck & Co. With 2012 sales of $370 million, the API business includes manufacturing plants in the Netherlands, a facility in Iowa, and an Illinois sales office. Aspen will pay about $47 million for the business and $390 million for existing inventory. The deal also includes a 10-year agreement to supply APIs to Merck. Aspen could pay another $600 million for the 11 products, which span several therapeutic areas and netted $248 million in sales last year.
This article has been sent to the following recipient: